Compare Immunovant Inc. Common Stock (IMVT) vs Liberty Energy Inc. Class A common stock (LBRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Liberty Energy Inc. Class A common stock — how do they compare? Immunovant Inc. Common Stock trades at $30.38 (market cap $6.25B), while Liberty Energy Inc. Class A common stock trades at $19.04 (market cap $3.08B). The key difference: Immunovant Inc. Common Stock is far larger — about 2× Liberty Energy Inc. Class A common stock's market cap, and Liberty Energy Inc. Class A common stock pays a 1.91% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Liberty Energy Inc. Class A common stock for 0 Days on average.
| IMVT | LBRT | |
|---|---|---|
Market Cap | $6.25B | $3.08B |
Volume | 1,755,411 | 4,917,315 |
Sector | Health | Energy |
52-Week High | $44.96 | $33.93 |
52-Week Low | $17.03 | $11.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $4.13B |
Dividend Yield | — | 1.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Liberty Energy Inc. Class A common stock
Liberty Energy provides completion services and technologies for onshore oil, natural gas, and geothermal producers in North America. It also offers distributed power and energy-storage solutions through Liberty Power Innovations.
Read more on LBRT →
